证券记录 · 已归档季度
SRPT
Sarepta Therapeutics, Inc. · Healthcare · Biotechnology
15被追踪持有人
-1Δ持有人
40.14M持有股份
$686.46M报告持仓市值
+1新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 -6.2% ·
股份流向 +24.2% ·
净新建仓位 -6.7%
· 公式
集中增持：持股数量上升，持有人数量减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | -1 | 19.39K | $353,037 | n/a | −2 |
| Q2 2026 | 109 | +2 | 83.38M | $1.50B | +13 | −12 |
| Q1 2026 | 111 | +1 | 76.41M | $1.66B | +6 | −6 |
| Q4 2025 | 110 | +2 | 75.97M | $1.63B | +3 | n/a |
| Q3 2025 | 17 | 0 | 44.07M | $848.49M | +2 | −3 |
| Q2 2025 | 15 | -1 | 40.14M | $686.46M | +1 | −2 |
| Q1 2025 | 13 | -1 | 11.03M | $703.96M | +1 | −2 |
| Q4 2024 | 14 | -1 | 10.27M | $1.25B | +2 | −3 |
| Q3 2024 | 14 | +1 | 7.65M | $955.24M | +1 | n/a |
| Q2 2024 | 13 | n/a | 7.85M | $1.24B | n/a | n/a |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 12.12M | n/a | $207.17M | 0.0% | n/c | 1 | SEC ↗ ×18 |
| 2 | The Vanguard Group ✦ (被动) | 9.16M | n/a | $156.64M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (被动) | 4.70M | +15.4% | $80.28M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | D. E. Shaw & Co. ✦ | 4.48M | +101548.6% | $76.58M | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 5 | Wellington Management ✦ | 2.53M | -4.4% | $43.27M | 0.0% | ▼ Trim | 5 | SEC ↗ ×5 |
| 6 | Two Sigma Investments ✦ | 2.16M | +292.4% | $36.97M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 7 | Geode Capital Management ✦ (被动) | 1.88M | +3.0% | $32.08M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 8 | Millennium Management ✦ | 1.06M | +413.3% | $18.16M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 9 | Norges Bank ✦ (被动) | 913.41K | -23.4% | $15.62M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 10 | Renaissance Technologies ✦ | 624.48K | 新增 | $10.68M | 0.0% | New | 1 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 302.16K | +28.1% | $5.17M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 125.98K | +2239.4% | $2.15M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 13 | T. Rowe Price ✦ | 76.78K | -67.8% | $1.31M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 14 | Fisher Asset Management ✦ | 12.91K | +1.2% | $220,761 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 15 | Fidelity (FMR) ✦ | 8.20K | n/a | $140,137 | 0.0% | n/c | 1 | SEC ↗ ×2 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Renaissance Technologies | $10.68M | 0.0% |
已清仓
| Marshall Wace | $1.74M | 曾为 0.0% |
| Bridgewater Associates | $1.26M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 339 持有人, 102.41M 股份, $2.16B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
Aug 13
SC 13G/A: AQR CAPITAL MANAGEMENT LLC
Aug 07
SC 13G: STATE STREET CORP
Jul 31
SC 13G/A: VANGUARD PORTFOLIO MANAGEMENT LLC
Jul 30
SC 13G/A: BlackRock, Inc.
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据